Stage I is characterized by a small genital papule or vesicle that appears between

3 and 30 days after exposure. The patient usually is asymptomatic; the ulcer heals

rapidly and leaves no scar. This primary lesion is consistent with that reported by

S.F. Many patients with LGV recall no primary lesion. Stage II is characterized by

acute, painful lymphadenitis with bubo formation (the inguinal syndrome); it is often

accompanied by pain and fever, as illustrated by S.F. Without treatment, the buboes

may rupture, forming numerous sinus tracts that drain chronically. Adenopathy above

and below the inguinal ligament results in the “groove sign.” Healing occurs slowly,

and most patients suffer no serious sequelae. Patients in this stage may also present

with an anogenitorectal syndrome, which is accompanied by proctocolitis and

hyperplasia of intestinal and perirectal lymphatic tissue. Stage III is characterized by

perirectal abscesses, rectovaginal fistulae (in women), rectal strictures, and genital

elephantiasis.

68 Appropriate treatment of stage II LGV usually prevents these late

complications.

An acute anorectal syndrome of LGV occurs in homosexual men who acquire the

infection through rectal receptive intercourse. In these cases, a primary anal ulcer

may be noted with associated inguinal adenopathy (anal lymphatics drain to inguinal

nodes). Subsequently, acute hemorrhagic proctocolitis occurs with tenesmus, rectal

pain, constipation, and a mucopurulent, bloody rectal discharge. Rectal biopsy may

show granulomatous colitis, mimicking Crohn’s disease. Perirectal pelvic

adenopathy also occurs.

p. 1516

p. 1517

TREATMENT

CASE 72-6, QUESTION 2: How should S.F. be treated?

Current CDC recommendations for LGV include doxycycline 100 mg PO twice

daily or erythromycin base 500 mg PO 4 times a day for 21 days.

2 Surgical

intervention may be needed for later forms of the disease. Azithromycin 1 g weekly

for 3 weeks may be effective, as well as fluoroquinolones, but clinical data on its use

are lacking.

2

SYPHILIS

Epidemiology

Syphilis is caused by the spirochete, Treponema pallidum. The rates of primary and

secondary syphilis in the United States increased in the late 1980s secondary to crack

cocaine use (and associated unsafe sex practices), but from 1990 to 2000 the rates

have decreased to those reported in 1941 when reporting began, representing a

89.7% decrease since 1990.

4

,

69

,

70 However, the number of cases of primary and

secondary syphilis have steadily risen since 2000, reaching a high of 17,375 cases in

2013.

4 Another concern is that syphilis facilitates the transmission of HIV, and a high

proportion of syphilis is reported in HIV-positive MSM.

4

,

71 Since 2008, the rates of

congenital syphilis have not increased until 2013, when 348 cases were reported to

the CDC representing 8.7 cases per 100,000 individuals, a 0.3% increase from 2012

(Fig. 72-5).

3 This increase was attributable to the increase in the rate of primary and

secondary syphilis cases in the West among females during 2010 to 2013. The

Healthy People 2020 (HP) goals for primary and secondary syphilis among women is

1.4 cases per 100,000 individuals and among men it is 6.8 cases per 100,000

individuals (Fig. 72-6).

5

The clinical manifestations of syphilis have not changed appreciably since their

first description. However, early diagnosis, treatment, and greater physician/patient

awareness of the disease have reduced the incidence of its severe forms. Penicillin

continues to be the mainstay of therapy.

Clinical Stages

CASE 72-7

QUESTION 1: D.M., a 27-year-old homosexual man, presents to the STD clinic with complaints of malaise,

headache, and fever of 4 days’ duration. He also reveals that he had a sore on his penis about 8 weeks ago, but

it has since resolved. Upon examination, he is afebrile and has a widespread maculopapular skin rash that

involves the soles of his feet; general lymphadenopathy also is appreciated. Medical history is unremarkable

except for one episode of gonorrhea 2 years ago that was treated with procaine penicillin. Laboratory findings

include a normal peripheral WBC count, a negative serology for HIV antigen, and a positive rapid plasma reagin

(RPR) test and fluorescent treponemal antibody absorption (FTA-ABS) test. Describe the clinical course of

syphilis. Are D.M.’s symptoms consistent with this infection?

PRIMARY STAGE

The average incubation period for syphilis is 3 weeks and ranges from 10 to 90

days.

72 During this incubation period, T. pallidum can be demonstrated in the lymph

and blood. The primary chancre develops at the site of inoculation as a painless

papule that becomes ulcerated and indurated. The ulcer is nontender and filled with

spirochetes. The chancre usually involves the penis in the heterosexual male; the

penis or anus in the homosexual male; and the vulva, perineum, or cervix in the

female. Occasionally, the lip or tongue is involved. Regional lymph nodes are

enlarged, firm, and nontender. Unfortunately, the typical chancre described earlier

often is missed, particularly in women or homosexual men.

73 Without treatment, the

primary chancre resolves spontaneously, usually in 2 to 6 weeks. The differential

diagnosis of genital ulcers also includes chancroid and genital herpes. Like

chancroid, genital herpes produces painful, superficial, nonindurated ulcers with

tender inguinal adenopathy. However, unlike chancroid, lesions of genital herpes

characteristically proceed through a vesicular state and often are associated with

urethritis, cervicitis, and constitutional symptoms, such as fever and chills. Syphilis

can be differentiated from herpes by a nonpainful versus painful lesion, a papular

versus vesicular appearance, and single versus multiple lesions. Chancroid is more

difficult to differentiate from syphilis, although chancroid tends to have a moretender lesion, jagged border, and striking inguinal lymphadenopathy.

72

Figure 72-5 Congenitalsyphilis—Reported cases among infants by year of birth and rates of primary and

secondary syphilis among women, 2004 to 2013. Reprinted from Centers for Disease Control and Prevention.

Sexually Transmitted Disease Surveillance 2013. Atlanta, GA: US Dept of Health and Human Services; 2014.

p. 1517

p. 1518

Figure 72-6 Syphilis—Reported Cases by Stage of Infection, United States, 1941 to 2013. Note: the Healthy

People 2020 target for primary and secondary syphilis is 1.4 new cases per 100,000 for females and 6.8 new cases

per 100,000 for males. Reprinted from Centers for Disease Control and Prevention. Sexually Transmitted Disease

Surveillance 2013. Atlanta, GA: US Dept of Health and Human Services; 2014.

SECONDARY STAGE

Approximately 6 weeks after a chancre first appears, the untreated patient manifests

signs and symptoms of the secondary stage of syphilis. This stage is currently

evidenced by D.M. Skin lesions of secondary syphilis may erupt in a variety of

patterns and are usually widespread in distribution. A macular lesion is often the

earliest manifestation in this stage. The lesion is round or oval, occurs primarily on

the trunk, and is rose or pink in color. As lesions mature, they become papular or

nodular with scaling (the so-called papulosquamous rash). The differential diagnosis

of diffuse papulosquamous rashes includes psoriasis, pityriasis rosea, and lichen

planus. In syphilis, the palms and soles are characteristically involved, and oral

lesions (mucous patches) may occur. Generalized lymphadenopathy usually is

present, and patchy alopecia may be seen. The most infectious lesion of secondary

syphilis is condyloma latum. Condylomata lata are characteristically wet, indurated

lesions occurring primarily in the perineum or around the anus as a result of direct

spread from the primary lesion. Laboratory studies sometimes reveal anemia,

leukocytosis, or an increased erythrocyte sedimentation rate. Other manifestations of

secondary syphilis include mild hepatitis, aseptic meningitis, uveitis, neuropathies,

and glomerulonephritis.

74

LATENT STAGE

By definition, untreated, asymptomatic persons with serologic evidence for syphilis

have latent syphilis. The latent stage is divided into two phases: the early latent (<1

year’s duration) and late latent (>1 year’s duration). In the Oslo study of patients with

untreated syphilis, 25% experienced secondary relapses, usually within the first

year.

75 Patients who relapse to the secondary stage are infectious; those in the late

latent stage are not infectious and are immune to reinfection with T. pallidum.

TERTIARY STAGE

Serious morbidity and mortality are caused by pathologic progresses involving the

skin, bones, central nervous system, and cardiovascular system. Infectious

granulomas (gummas), the characteristic lesions of tertiary syphilis, are observed

infrequently. Most gummas respond quickly to specific therapy, although if critical

organs are involved (heart, brain, liver), they can be fatal.

76 The most common

manifestations of syphilitic cardiovascular disease are aortic insufficiency and

aortitis, with aneurysm of the ascending aorta.

Neurosyphilis may be classified as asymptomatic early or late, meningeal,

parenchymatous, or gummatous. Although neurosyphilis has been a rare complication

for more than 40 years because of the widespread of use of penicillin, syphilitic

meningitis, an early form of neurosyphilis, may be more common in HIV-positive

patients.

72

,

77 Late neurosyphilis may be asymptomatic or accompanied by a variety of

manifestations; the most common syndromes are meningovascular syphilis, general

paresis, tabes dorsalis (locomotor ataxia), and optic atrophy. In patients with

asymptomatic neurosyphilis, examination of the cerebrospinal fluid (CSF) typically

reveals mononuclear pleocytosis, an elevated protein concentration, and a positive

VDRL reaction.

Patients with asymptomatic neurosyphilis are at increased risk for experiencing

neurologic disease. Meningovascular syphilis, accounting for almost 38% of all

cases of neurosyphilis, typically begins abruptly with hemiparesis or hemiplegia,

aphasia, or seizures.

78 General paresis is characterized by extensive parenchymal

damage and includes abnormalities associated with the mnemonic PARESIS

(personality, affect, reflexes [hyperactive], eye [Argyll Robertson pupil], sensorium

[hallucination, delusions, illusions], intellect [decreased recent memory,

calculations, judgment], and speech). Tabes dorsalis occurs after demyelinization of

the spinal cord. Symptoms observed include an ataxic, wide-based gait and foot slap;

paresthesias; bladder irregularities; impotence; areflexia; and loss of position, deep

pain, and temperature sensation. The Argyll Robertson pupil, seen in both paresis

and tabes dorsalis, is a small, irregular pupil that reacts to accommodation but not to

light.

p. 1518

p. 1519

Laboratory Tests

CASE 72-7, QUESTION 2: Evaluate D.M.’s laboratory findings.

DARK-FIELD EXAMINATION

Exudate expressed from the chancre or from condyloma latum is examined with a

dark-field microscope. The diagnosis of syphilis is made if spirochetes with

characteristic corkscrew morphology and mobility are present. Dark-field

examination is the most specific and sensitive method but only with an experienced

microscopist.

79

,

80 Three dark-field examinations on consecutive days should be

performed before considering the test negative in suspected primary syphilis. This

technique and other methods, such as DFA and PCR, which detect T. pallidum

directly from exudate or tissue are definitive diagnostic methods for syphilis.

SEROLOGIC TESTS

Serologic tests become reactive during the primary stage, but they may be negative at

the time of presentation with primary syphilis. When the history or examination

suggests primary syphilis, a VDRL should be sent to the laboratory, or an RPR test

should be performed in the clinic (see discussion on nontreponemal tests, next). If

initial serology and dark-field examinations are negative, the serology should be

repeated in 1 to 4 weeks to exclude primary syphilis. If the dark-field examination is

positive, an RPR may still be ordered to establish a baseline for follow-up after

treatment.

Serologic tests are uniformly positive in secondary syphilis.

72 Two types of tests

are used for the serodiagnosis of syphilis: nontreponemal tests, which measure serum

concentrations of reagin (antibody to cardiolipin), and treponemal tests, which detect

the presence of antibodies specific for T. pallidum.

Nontreponemal Tests

Nontreponemal tests are not specific for T. pallidum but can be quantified. They are

inexpensive and useful for screening large numbers of people. The most widely used

nontreponemal tests are the VDRL test and the RPR Card Test. The RPR test is the

most widely used because it is simpler to perform than the VDRL. Although they are

equally valid assays, results of the VDRL and RPR are not interchangeable; thus, the

same test should be used throughout the posttreatment monitoring period.

2

,

81

The result reported in the quantitative VDRL test is the most dilute serum

concentration with a positive reaction. This test may be used to follow the decline in

VDRL titer after effective therapy (see Case 72-7, Question 5). In some individuals,

a serofast reaction occurs in which nontreponemal antibodies may remain at a low

titer for up to their entire lives. When false-positive tests occur, the titer usually is

low (e.g., VDRL or RPR titer of 1:8).

82

In secondary syphilis, sensitivity of the RPR

and VDRL approach 100% owing to the high antibody concentrations.

83

Treponemal Tests

Specific treponemal tests, such as FTA-ABS, T. pallidum particle agglutination

assay (TP-PA), and various EIAs, confirm a positive nontreponemal test. The FTAABS test is the most commonly used treponemal test. Because treponemal tests are

relatively difficult and expensive to perform, they are not traditionally used for

screening.

Treatment

CASE 72-7, QUESTION 3: How should D.M. be treated?

The CDC recommends penicillin G for the treatment of all stages of syphilis

(Table 72-4).

2 Every effort should be made to rule out penicillin allergy before

choosing alternative agents. Considering that penicillin-resistant T. pallidum has

never been observed, treatment regimens for syphilis have changed relatively little

during the years.

As shown in Table 72-4, recommended therapy for primary, secondary, or latent

syphilis (with negative findings in the CSF) of less than 1 year’s duration is a single,

IM 2.4 million-unit dose of benzathine penicillin G. If penicillin is contraindicated,

tetracycline 500 mg PO 4 times a day or doxycycline 100 mg PO twice a day for 14

days are the main alternatives. If the patient is allergic to penicillin, is not pregnant,

and cannot receive tetracycline or doxycycline, a 10- to 14-day regimen of

ceftriaxone 1 g IM or IV every day or a single 2 g dose of azithromycin are options.

2

The use of erythromycin as an alternative is no longer recommended by the CDC

because of its poor efficacy. The optimal dose, duration, and efficacy of these

alternative regimens are not well-defined, necessitating close follow-up of patients.

However, recent studies have shown that azithromycin 2 g PO as a 1-time dose is at

least equivalent to benzathine penicillin G.

84

,

85 Skin testing should be performed for

individuals who claim allergy to penicillin. If the patient is truly allergic, he or she

should be desensitized.

2 Late latent syphilis (>1 year’s duration) and tertiary syphilis

(gummas or cardiovascular syphilis) are treated with IM benzathine penicillin G

(50,000 units/kg, up to 2.4 million-units) weekly for a total of 3 weeks.

2

NEUROSYPHILIS

CASE 72-7, QUESTION 4: Would D.M.’s treatment differ if his CSF had tested positive for syphilis?

Neurosyphilis can present at any stage of syphilis. When conventional IM doses of

benzathine penicillin G are administered, measurable levels of penicillin are not

obtainable in the CSF. However, this does not mean that penicillin does not

concentrate in meningeal tissue.

86 Treatment failures, as well as late clinical

progression to neurosyphilis, can occur after treatment with the recommended IM

regimen. After one dose, benzathine penicillin reaches peak plasma concentrations

slower (13–24 hours) but with more prolonged treponemicidal plasma

concentrations (7–10 days) when compared with procaine penicillin (1–4 hours to

peak; 12–24 hour treponemicidal plasma concentrations).

86 Reports of benzathine

penicillin failures in the 1970s has resulted in the CDC recommending treatment with

aqueous crystalline penicillin G, 3 to 4 million-units IV every 4 hours, or 18 to 24

million-units per day continuous infusion for 10 to 14 days. Alternatively,

neurosyphilis can be treated with concurrent procaine penicillin (2.4 million-units

IM daily) and probenecid (500 mg PO 4 times a day) for 10 to 14 days. Some experts

add benzathine penicillin G (2.4 million-units IM once a week for up to 3 weeks)

after the completion of aqueous penicillin G or procaine penicillin.

2 Penicillinallergic patients should be skin tested to confirm allergy and, if confirmed, the patient

should be desensitized and treated with an appropriate penicillin regimen. Some data

suggest that ceftriaxone 2 g IM or IV daily for 10 to 14 days can be used as an

alternative in patients whose concern for cross-sensitivity between ceftriaxone and

penicillin is negligible.

2 Alternatively, the World Health Organization recommends

penicillin-allergic nonpregnant patients receive either doxycycline 200 mg PO twice

a day or tetracycline 500 mg PO 4 times a day for 30 days.

87

FOLLOW-UP

CASE 72-7, QUESTION 5: D.M. was treated with a single IM dose of benzathine penicillin (2.4 millionunits). How should his response to therapy be monitored?

p. 1519

p. 1520

Table 72-4

Treatment Guidelines for Syphilis

Stage Recommended Regimen Alternative Regimen

Early (primary, secondary, or early

latent)

a

Benzathine penicillin G 2.4 millionunits single dose IM

Doxycycline 100 mg PO BID for

14 days or

Tetracycline 500 mg PO QID for

14 days or

Ceftriaxone 1 g IM/IV every day

for 8 to 10 days or

Azithromycin 2 g PO × 1 dose

Late latent or latent syphilis of

unknown duration

Lumbar puncture Lumbar puncture

If CSF normal: benzathine penicillin

G 2.4 million-units/week × 3 weeks

IM

If CSF normal: doxycycline 100 mg

PO BID for 28 days or

Tetracycline 500 mg PO QID for

28 days

If CSF abnormal: Treat as If CSF abnormal: treat as

neurosyphilis neurosyphilis

Neurosyphilis

b

(asymptomatic or

symptomatic)

Aqueous crystalline penicillin G 18–

24 million-units IV every day × 10–

14 days

c

Procaine penicillin 2.4 million-units

IM daily plus probenecid 500 mg

PO QID, both for 10–14 days

Congenital Aqueous crystalline penicillin G

100,000–150,000 units/kg/day,

administered as 50,000

units/kg/dose IV q12h during the

first 7 days of life, and every 8

hours thereafter for a total of 10

days

d

If CSF normal: benzathine penicillin

G 50,000 units/kg/dose IM in a

single dose

Procaine penicillin G 50,000

units/kg/dose IM a day in a single

dose for 10 days

Syphilis in pregnancy According to stage According to stage

aSome experts recommend repeating this regimen after 7 days for HIV-infected patients.

bBecause of the shorter duration of therapy as compared with latent syphilis, some experts recommend giving

benzathine penicillin G, 2.4 million-units/week for up to 3 weeks, after the completion of these neurosyphilis

regimens to provide a comparable total duration of therapy.

cAdministered as 3–4 million-units IV every 4 hours or continuous infusion.

dAll infants born to women treated during pregnancy with erythromycin must be treated with penicillin at birth.

Adapted from Workowski KA, Bolan GA; Centers for Disease Control and Prevention (CDC). Sexually

transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.

Physical examination and a quantitative VDRL or RPR test for primary and

secondary syphilis should be repeated at least 6 and 12 months after therapy.

2

Retreatment should be considered when the RPR or VDRL titer does not decline

fourfold in 6 months. Patients with HIV coinfection should receive periodic serologic

testing.

72 Patients with latent syphilis should be retested 6, 12, and 24 months after

treatment. Close serologic monitoring is necessary if antibiotics other than penicillin

are used; CSF examination should be performed in these patients at their last followup visit. Patients with neurosyphilis should be monitored serologically every 6

months; CSF examinations should be repeated at 6-month intervals until normal. If

still abnormal at 2 years, retreatment should be considered. Return of lesions, a

fourfold increase in titer, or a titer of 1:8 that does not fall at least fourfold within 12

months necessitates retreatment. Suspected treatment failures, especially with

abnormal CSF, should be treated as described for neurosyphilis. However, falsepositive serologic results should be ruled out.

Within 2 years, most patients with early syphilis become seronegative. However,

if the disease is treated during the late stages, complete seroreversion may not occur.

Patients treated with oral doxycycline or erythromycin are less likely to become

seronegative.

88 Therapy is considered adequate in patients who never become

seronegative as long as the titer decreases fourfold. Although the disease process

may be halted in patients with tertiary syphilis, existing damage to the cardiovascular

or nervous systems cannot be reversed.

PREGNANCY

CASE 72-8

QUESTION 1: N.W., a 27-year-old woman in her 19th week of gestation, has a positive VDRL and FTAABS. How should N.W. be managed? How would management be altered in the face of penicillin allergy?

Although pregnancy may be associated with false-positive nontreponemal tests,

74

the presence of both a positive treponemal test (e.g., FTA-ABS) and a nontreponemal

test (e.g., RPR) virtually excludes a false-positive reaction.

80 The next step is to

determine whether N.W. already has been treated adequately. If she has previously

received adequate treatment and follow-up and shows no evidence of persistence or

recurrence of syphilis, then she requires no further therapy. Pregnancy has no known

effect on the clinical course of syphilis.

89 However, her infant should be observed

carefully. If N.W. has not been treated previously for syphilis, then she should be

treated with penicillin in the same doses recommended for nonpregnant women; some

experts recommend a second dose 1 week later of 2.4 million-units of benzathine

penicillin.

2

The goal of therapy should be to treat the mother with syphilis as soon as possible.

Syphilis transmission can occur transplacentally as early as 9 to 10 weeks’ gestation

via direct contact with lesions in the birth canal.

89

,

90

If the mother is left untreated,

70% to 100% of fetuses born to mothers with primary or 40% with secondary

syphilis may be aborted, stillborn, or born with congenital syphilis (see Case 72-8,

Question 3).

91

,

92

p. 1520

p. 1521

There is no completely satisfactory alternative for the pregnant woman with an

accelerated allergic reaction to penicillin. Tetracycline, as well as doxycycline,

should be avoided during pregnancy, especially during the second or third trimester,

because of tetracycline’s known effects on the fetus (tooth staining and inhibition of

bone growth).

93 Erythromycin has been used to treat pregnant patients with syphilis;

however, the transplacental transfer rate of erythromycin is inadequate,

94 potentially

explaining the increased rate of aborted or stillborn infants in erythromycin-treated

patients. Erythromycin and azithromycin are not recommended as alternative therapy

for syphilis during pregnancy.

2 A woman with a history of allergy to penicillin should

be skin tested; if allergy is confirmed, she should be desensitized and treated with

penicillin.

2

It is possible that the newer cephalosporins may ultimately prove to be

acceptable alternatives to penicillin G in the pregnant woman with syphilis, who is

allergic to penicillin, but there is sufficient evidence for the CDC to recommend their

use. Adequate treatment with penicillin can prevent up to 98% of fetal infections.

95

,

96

Serologic titers, at a minimum should be followed up at 28 to 32 weeks’ gestation

and at delivery. Monthly serologic titers may be considered in women at high risk for

reinfection or those in geographical areas of high syphilis rates; thereafter, she should

be followed up as any other patient with syphilis.

2

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more